United States · Investor

Convergent Ventures

Last cheque observed Oct 2026; 4 cheques on record.

VC firmDeploying now

SeedPre-seedHealthSustainability

Deploying now
100%of best year1cheques in 12 months, 4 on record
Since the last cheque34days00hrs00min00sec
Median round$15MRounds led0 of 4
Pitch Convergent Ventures

Convergent Ventures highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 100% of its rounds

What they do

We actively scout, invest in, and nurture early-stage teams whose passion and product lie at that intersection.From their own website
Type
VC firm
Cheque size
Not stated
Stages
SeedPre-seed
Sectors
HealthSustainability
Based in
San Francisco, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first4 appearances

  1. 2026

    1 round

  2. Oct
    BiotiaSeries A · US · Firms' own news pages$9.0MWith 11 others
  3. 2024

    1 round

  4. Dec
    FibreCoatSeries B · DE · Silicon Canals$21MWith 8 others
  5. 2015

    2 rounds

  6. Jul
    PaktorSeries B · SG$7.5MWith 3 others
  7. Jul
    AdskomSeries A · SGUndisclosedWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

CLChristina Lee JenkinsManaging Member, Convergent Seed Fund GP, LLCiForm ADV
FHFrank Howard LevinsonMember and Managing DirectoriForm ADV
JMJulia Marie Alexandra DavourieMember and Managing DirectoriForm ADV

We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$40Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Convergent Ventures LLC
SEC number
CRD 326986

What they claim to have backed

From their own portfolio page (on their website)

10 of 18 we have independently watched raise

AbsciAgrologyAnametricBiotiaContralineFibrecoatNozePulseindustrialSonicincytesUbiceptDandelionhealthEnosemiFigur8techNovameraincProfluentTensorbioValencelabsWavefrontdynamics

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as Convergent Ventures. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Convergent Ventures put money into.

Quick answers about Convergent Ventures

What does Convergent Ventures invest in?

Convergent Ventures invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Health and Sustainability.

How active is Convergent Ventures?

4 investments on record, 1 of them in the last 12 months. The most recent was in Oct 2026.

What has Convergent Ventures invested in recently?

Its most recent investments on record: Biotia (Series A, Oct 2026) and FibreCoat (Series B, Dec 2024).

How big are Convergent Ventures's cheques?

The median round it joins is $15M.

Is Convergent Ventures investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

Who does Convergent Ventures invest alongside?

Most often Convergence Ventures (2 rounds together).

What kind of investor is Convergent Ventures?

Convergent Ventures is a VC firm based in San Francisco, United States.

How much does Convergent Ventures manage?

About $40M, as gross assets of its private funds (Oct 2026).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it